|Brand name(s), other common name(s)||Inrebic®|
|Drug type||Kinase inhibitor|
|How the drug is given||Oral|
Indications and Usage
Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).
Side effects needing medical attention
Diarrhea, nausea, anemia, and vomiting.